Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Nefrología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
INTERVENTIONAL
Inicio: 25 de ene de 2021
ID: NCT04578834
Completado
Fase 3
ClinicalTrials.gov
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
INTERVENTIONAL
Inicio: 5 de mar de 2018
ID: NCT03409107
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
INTERVENTIONAL
Inicio: 1 de ene de 2023
ID: NCT05678673
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects With Localized or Locally Advanced RCC Following Nephrectomy
INTERVENTIONAL
Inicio: 30 de nov de 2010
ID: NCT01235962
Reclutando
Fase 2
ClinicalTrials.gov
An Open-label, Long-term Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
INTERVENTIONAL
Inicio: 25 de feb de 2025
ID: NCT06712823
Completado
Fase 2
ClinicalTrials.gov
An Open-label, Multicenter Phase II Study to Compare the Efficacy and Safety of RAD001 as First-line Followed by Second-line Sunitinib Versus Sunitinib as First-line Followed by Second-line RAD001 in the Treatment of Patients With Metastatic Renal Cell Carcinoma.
INTERVENTIONAL
Inicio: 1 de oct de 2009
ID: NCT00903175
Completado
Fase 4
ClinicalTrials.gov
Maraviroc Switch Collaborative Study Renal Substudy
INTERVENTIONAL
Inicio: 1 de jun de 2012
ID: NCT01637259
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo Controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients With Locally Advanced and/or Metastatic Renal Cell Carcinoma
INTERVENTIONAL
Inicio: 1 de abr de 2006
ID: NCT00334282
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled 12-Week Study to Evaluate the Safety and Efficacy of Oral Difelikefalin in Advanced Chronic Kidney Disease Subjects With Moderate-to-Severe Pruritus With an up to 52-Week Long-term Extension
INTERVENTIONAL
Inicio: 26 de ago de 2022
ID: NCT05356403
Anterior
1
...
17
18
19
...
434
Siguiente
Filtros